Named Bioactive Compounds · Compound
Ruscogenin (Saponin)
Moderate Evidencesaponin
Hermetica Superfood Encyclopedia
Ruscogenin is a steroidal saponin compound extracted from Ruscus aculeatus (butcher's broom) that demonstrates anti-inflammatory and vasoprotective properties. This bioactive saponin works by modulating inflammatory pathways and supporting vascular endothelial function.
Ruscogenin is a steroidal saponin characterized by a C27 carbon skeleton derived from oxidized cholesterol, primarily extracted from the underground parts (rhizomes and roots) of plants in the Ruscus genus, especially Ruscus aculeatus (butcher's broom). Extraction involves fractionation of methanol extracts followed by hydrolysis using alkaline or acid conditions to release the free aglycone from glycosides like ruscoside and ruscin.
No specific human clinical trials, RCTs, or meta-analyses directly on isolated ruscogenin were found in the research. Available studies focus on Ruscus extracts containing ruscogenin as a marker compound, with noted anti-inflammatory, antioxidant, and vasoprotective effects in pharmacological research only.
No clinically studied dosage ranges for ruscogenin in extract, powder, or standardized forms are available. Current research mentions it only as a principal aglycone in Ruscus aculeatus saponins without providing standardization percentages or dosing data. Consult a healthcare provider before starting any new supplement.
Ruscogenin is a steroidal sapogenin (aglycone form of saponins) with molecular formula C27H42O4 and molecular weight of approximately 430.62 g/mol. It is not a macronutrient or micronutrient in the traditional dietary sense but rather a bioactive phytochemical compound. As a pure isolated compound, it contains no protein, carbohydrates, dietary fiber, vitamins, or minerals in its isolated form. Structurally, it belongs to the spirostanol-type steroidal saponin class, characterized by a fused tetracyclic ring system with hydroxyl groups at C-1 and C-3 positions. In its natural source (Ruscus aculeatus, butcher's broom), ruscogenin occurs primarily as glycosylated saponins at concentrations of approximately 1–3% of dry root weight, with ruscogenin and neoruscogenin being the two primary aglycones. Bioavailability of steroidal saponins is generally low when orally administered (estimated <10% absorption in unmodified form) due to poor aqueous solubility and limited intestinal permeability; hydrolysis by gut microbiota to the aglycone form may modestly improve absorption. The compound demonstrates lipophilic characteristics (logP approximately 3.5–4.5), influencing its membrane interaction capacity. No caloric value is assigned as it is consumed in trace pharmacological quantities rather than as a food nutrient.
Ruscogenin exerts its effects by inhibiting nuclear factor-kappa B (NF-κB) signaling pathways, reducing pro-inflammatory cytokine production including TNF-α and IL-6. The compound also enhances nitric oxide bioavailability and protects vascular endothelial cells from oxidative damage. Additionally, ruscogenin modulates calcium channels and exhibits α1-adrenergic receptor antagonist activity in vascular smooth muscle.
Current evidence for ruscogenin is limited to pharmacological research conducted primarily in rodent models and in vitro studies. These preliminary studies have demonstrated anti-inflammatory effects with reductions in inflammatory markers, though specific dosages and effect sizes vary across studies. Antioxidant activity has been observed in cell culture experiments, showing protection against oxidative stress markers. No large-scale human clinical trials have been conducted to establish therapeutic efficacy or optimal dosing protocols for ruscogenin supplementation.
Safety data for ruscogenin is limited due to the lack of comprehensive human studies. Potential interactions may occur with anticoagulant medications due to its vascular effects, though specific drug interactions have not been well-documented. Pregnant and breastfeeding women should avoid ruscogenin supplementation due to insufficient safety data. Individuals with bleeding disorders or those scheduled for surgery should exercise caution when considering ruscogenin-containing supplements.
